Mg 5-Sulfat Amp. Drossapharm Gmbh (Magnesium Sulfate Heptahydrate)

Magnesium sulfate releases Mg2+ ions that act as calcium antagonists, reducing calcium entry into cells. This leads to smooth‑muscle relaxation, vasodilation, and stabilization of neuronal membranes, while also serving as a co‑factor for many enzymatic processes that maintain electrolyte and energy balance.

The appropriate dose is determined by the prescribing clinician based on the patient’s condition, serum magnesium level, weight, and route of administration. Healthcare professionals adjust the regimen to achieve therapeutic goals while avoiding toxicity.

Magnesium sulfate is commonly used in obstetric care, especially for eclampsia prevention, but its safety depends on gestational age and clinical context. Clinicians weigh benefits against potential risks, and breastfeeding mothers should consult a healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with potassium or calcium salts, magnesium sulfate uniquely addresses magnesium deficiency and provides vasodilatory and anticonvulsant effects. It is preferred in obstetric emergencies and specific cardiac arrhythmias, whereas other electrolytes target different physiologic deficits.

Mg 5‑Sulfat Amp. Drossapharm should be stored below 25 °C, in its original sealed ampoule, protected from moisture and direct light. Do not freeze the product, and handle with aseptic technique to maintain sterility.

The ampoule is intended for intramuscular or intravenous injection. Administration is performed by qualified healthcare personnel using aseptic technique, with the dose and rate determined by the prescriber according to the clinical indication.

Serious risks include hypermagnesemia, which can cause respiratory depression, severe hypotension, cardiac arrest, and neuromuscular blockade. Prompt monitoring of serum magnesium and clinical signs is essential, especially in patients with renal impairment or when high doses are used.

Patients with known hypersensitivity to magnesium sulfate, severe renal failure, advanced heart block without a pacemaker, or myasthenia gravis should generally avoid this medication unless a specialist determines that benefits outweigh risks.